**Charity registration number 1189777 (England and Wales)**
## **INTERNATIONAL INSTITUTE FOR RESTORATIVE REPRODUCTIVE MEDICINE**
**ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS**
**FOR THE YEAR ENDED 30 JUNE 2025**
## **INTERNATIONAL INSTITUTE FOR RESTORATIVE REPRODUCTIVE MEDICINE**
## **LEGAL AND ADMINISTRATIVE INFORMATION**
|**Trustees**|Dr P Boyle||
|---|---|---|
||Dr J Stanford||
||Dr K McCarthy||
||Dr T Parnell||
||Dr J Arraztoa Valdivieso||
||Dr Z Horodenchuk||
|**Charity registration**|England and Wales|1189777|
|**Principal address**|Ground Floor||
||1 - 7 Station Road||
||Crawley||
||West Sussex||
||RH10 1HT||
|**Independent examiner**|Darren Harding ACA FCCA DChA||
||Richard Place Dobson Services Limited||
||Ground Floor||
||1-7 Station Road||
||Crawley||
||West Sussex||
||RH10 1HT||
## **INTERNATIONAL INSTITUTE FOR RESTORATIVE REPRODUCTIVE MEDICINE**
## **CONTENTS**
||**Page**|
|---|---|
|Trustees' report|1 - 4|
|Independent examiner's report|5|
|Statement of financial activities|6|
|Balance sheet|7|
|Notes to the financial statements|8 - 14|
## **INTERNATIONAL INSTITUTE FOR RESTORATIVE REPRODUCTIVE MEDICINE**
## **TRUSTEES' REPORT**
## _**FOR THE YEAR ENDED 30 JUNE 2025**_
The trustees present their annual report and financial statements for the year ended 30 June 2025.
The IIRRM unites providers and researchers in educating, researching and promoting scientifically-based and well researched reproductive health care services that cooperate with and restore reproductive function. Restorative Reproductive Medicine (RRM) exclusively focuses investigations and treatments on identifying and correcting abnormalities, restoring or optimizing natural reproductive function.
In the 2024 fiscal year, IIRRM continued to achieve significant milestones in advancing Restorative Reproductive Medicine (RRM) research, education, and global outreach. Key initiatives included the continued recruitment and data collection for the STORRM project, an international registry documenting RRM treatments for subfertility and miscarriage, along with their outcomes. This registry aims to provide patients, clinicians, and stakeholders with current, evidence-based insights into RRM practices and results.
We also established the RRM Clinician Recognition Program, creating a standardized process to recognize clinicians and ensure baseline training, excellence in practice, and ongoing professional development.
In support of continuing education, IIRRM hosted CME-accredited webinars 2-4 times monthly, delivering highquality scientific and clinical content and engaging with members and the RRM community. Additionally, we mentored and collaborated with other RRM organizations to enhance and encourage the delivery of their educational programs, maintaining rigorous scientific and clinical standards.
To foster new research, IIRRM’s abstract campaign highlighted 24 presentations at our annual meeting in August 2024 at the University of British Columbia in Vancouver, Canada. We also contributed to research efforts by supporting the publication of two new articles.
Membership growth, with new members joining from regions such as Southeast Asia, South America, and Africa, as well as continued expansion in Canada, Europe and the USA.
The financial statements have been prepared in accordance with the accounting policies set out in note 1 to the financial statements and comply with the Charity's governing document, the Charities Act 2011, FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Charities SORP "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)".
## **Objectives and activities**
The charitable objectives of IIRRM are to advance education, research, and clinical practice in restorative reproductive medicine (RRM) for the benefit of public health.
For the 2025 fiscal year the charity delivers its objectives through:
For the year ended 30 June 2025 – Trustee Activity Report
- Provision of continuing medical education (CME) and training programmes
- Hosting conferences and scientific meetings
- Supporting research and data collection initiatives
- Developing clinical guidance and standards
- Facilitating international collaboration among clinicians, researchers, and allied health professionals
The trustees have paid due regard to guidance issued by the Charity Commission in deciding what activities the Charity should undertake.
page 1
## **INTERNATIONAL INSTITUTE FOR RESTORATIVE REPRODUCTIVE MEDICINE**
## **TRUSTEES' REPORT (CONTINUED)**
## _**FOR THE YEAR ENDED 30 JUNE 2025**_
During the financial year, IIRRM made significant progress in expanding its educational, research, and clinical initiatives.
## **Launch of the Journal of Restorative Reproductive Medicine (JRRM)**
The charity successfully established and launched the Journal of Restorative Reproductive Medicine (JRRM), providing an academic platform dedicated to advancing evidence-based research in RRM. To support early adoption and encourage submissions, article processing charges (APCs) were initially waived.
## **Clinical Guidelines Development**
Initial work commenced on the development of clinical guidelines in restorative reproductive medicine. This work aims to support evidence-based practice and standardisation of care across international settings. This included structure, initial committee establishment and assessment on need and research.
## **RRM Clinician Recognition Program**
The charity expanded its Clinician Recognition Program, designed to:
- Recognise clinicians providing restorative reproductive medicine care
- Promote high standards and clinical excellence
- Support referral pathways for patients and fertility awareness-based method (FABM/NFP) educators
- Maintain an up to date network of qualified RRM clinicians
- Facilitate a patient referral programme, connecting individuals seeking care with appropriately trained and recognised RRM clinicians
The programme continues to strengthen collaboration and improve access to qualified RRM providers globally.
## **Education and Global Reach**
IIRRM expanded its educational activities, reaching participants in 62 countries.
Key educational initiatives included:
For the year ended 30 June 2025 – Trustee Activity Report
- Ongoing CME-accredited webinar series, including:
- ○Grand rounds
- ○Research updates
- ○Journal clubs delivered in English, Ukrainian, and Spanish
- ○Case discussion and reviews
Across all educational platforms, the charity delivered:
- Approximately 6,000 CME credit hours awarded through the annual conference
- Approximately 8,500 CME credit hours awarded through webinar programming
- Additional CME through additional enduring content and support of external RRM organisations’ accreditation activities
Continued growth (membership and attendance) in under-resourced and developing regions, support by IIRRM’s Global access program
## **Annual Scientific Meeting**
IIRRM hosted its largest annual meeting to date at the University of British Columbia, Vancouver, Canada, spanning four days. The meeting brought together an international audience of clinicians, researchers, and allied health professionals.
## **Research and Awards Programme**
The charity expanded its research engagement through:
- Continued growth in abstract submissions, with expanded opportunities for presentation, mentorship, and scholarly discussion.
- Introduction of annual research awards, including:
- ○Student Award
- ○Early Career Award
- ○Mid/Late Career Award
- ○Case/Case Series Award
These awards included financial support and presentation opportunities to encourage continued research in the field.
page 2
## **INTERNATIONAL INSTITUTE FOR RESTORATIVE REPRODUCTIVE MEDICINE**
## **TRUSTEES' REPORT (CONTINUED)**
## _**FOR THE YEAR ENDED 30 JUNE 2025**_
## **STORRM Registry**
IIRRM continued to contribute to and develop the Surveillance of Treatment Outcomes in Restorative Reproductive Medicine (STORRM) registry launched last year.
The registry aims to:
For the year ended 30 June 2025 – Trustee Activity Report
- help address the enormous need of subfertile couples for restorative treatment options that are viable, effective, costeffective, healthy, and consistent with all ethical values, while reducing or avoiding unnecessary interventions.
- provide reliable data that can be used to inform clinicians and patients about the probability of a live birth with RRM treatment, based on a couple’s clinical characteristics.
- provide reliable outcomes data to support third-party reimbursement for RRM services.
- compare outcomes (e.g., live birth rates) across countries, regions, clinics, and different developed and developing systems or approaches of RRM. This will support participating clinicians who wish to learn from each other to improve the practice of RRM.
- document improvements and changes in outcomes over time with changes in RRM practice and treatment.
- develop pilot data and infrastructure to inform future clinical trials of specific evaluations or interventions.
- raise visibility for RRM options for patients, clinicians, and other interested parties.
-
## **Infrastructure and Expansion**
During the year, the charity:
- Established as a registered chapter in Canada, to support growth in the local region and congress
- Expanded the USA chapter with an operational presence (office) in California to support growing activities in North America
- Implemented and licensed REDCap for research data management and project infrastructure
## **Financial review**
During the year to 30 June 2025 the charity made a surplus of £2,304 (year ended 30 June 2024 surplus of: £29,521).
Revenue and Expenditure:
- The bulk of revenue for the year that funds the IIRRM activities came from membership dues. Expenditures were balanced with income, supporting the various initiatives and programs undertaken.
Future Financial Plans:
- The Trustees plan to prioritize funding and grants for research and program continuation over the next three years as well as expanding membership reach. This will includes re-establishing the international advisory council, expanding education access, maintaining webinar series, and supporting an RRM journal.
It is the policy of the Charity that unrestricted funds which have not been designated for a specific use should be maintained at a level equivalent to between three and six month’s expenditure. The trustees consider that reserves at this level will ensure that, in the event of a significant drop in funding, they will be able to continue the Charity’s current activities while consideration is given to ways in which additional funds may be raised. This level of reserves has been increased within the year.
## **Plans for 2026-2027**
IIRRM plans to:
- Continue development of clinical guidelines in RRM
- Expand RRM educational programming, education and global reach
- Continue to support and provide mentorship and evidence-based information on RRM
- Ongoing development of the Journal of Restorative Reproductive Medicine (JRRM), with the objective of meeting criteria for indexing in PubMed/MEDLINE and the Directory of Open Access Journals (DOAJ) in 2-3 years
- Grow the STORRM registry, PROOF and associated research collaborations
- Expand the annual conference and strengthen professional networks through the 2026 Annual Meeting in Orlando, USA
- Strengthen clinician networks and training pathways
page 3
## **INTERNATIONAL INSTITUTE FOR RESTORATIVE REPRODUCTIVE MEDICINE**
## **TRUSTEES' REPORT (CONTINUED)** _**FOR THE YEAR ENDED 30 JUNE 2025**_
## **Structure, governance and management**
The Charity is a charitable incorporated organisation registered on 4th June 2020 with a CIO - Association governing document.
The trustees who served during the year and up to the date of signature of the financial statements were:
Dr P Boyle Dr J Stanford Dr K McCarthy Dr P Carpentier (Resigned 27 September 2025) Dr T Parnell Dr J Arraztoa Valdivieso Dr Z Horodenchuk
Currently Trustees are invited by the Board of Directors (Trustees) from amongst a list of members who have expressed interest in being involved in the organizations' management. When the current founding Board members' terms are complete, we will transition to elections for Trustees.
The Trustees meet once a month virtually or more if needed, the trustees also email/text or call if needed. The Director of Communications and Development is responsible for the daily operations and supervision of contractors, who perform most of the practical aspects such as answering emails and coordinating events/webinars/conferences etc.
The trustees' report was approved by the Board of Trustees.
.............................. Dr P Boyle **Trustee**
Date: April 30 2026
page 4
## **INTERNATIONAL INSTITUTE FOR RESTORATIVE REPRODUCTIVE MEDICINE**
## **INDEPENDENT EXAMINER'S REPORT**
## **TO THE TRUSTEES OF INTERNATIONAL INSTITUTE FOR RESTORATIVE REPRODUCTIVE MEDICINE**
I report to the trustees on my examination of the financial statements of International Institute for Restorative Reproductive Medicine (the Charity) for the year ended 30 June 2025.
## **Responsibilities and basis of report**
As the trustees of the Charity you are responsible for the preparation of the financial statements in accordance with the requirements of the Charities Act 2011.
I report in respect of my examination of the Charity’s financial statements carried out under section 145 of the Charities Act 2011. In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5)(b) of the Charities Act 2011.
## **Independent examiner's statement**
Your attention is drawn to the fact that the charity has prepared the financial statements in accordance with the relevant version of the Statement of Recommended Practice applicable to charities preparing their financial statements in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) in preference to the Accounting and Reporting by Charities: Statement of Recommended Practice issued on 1 April 2005 which is referred to in the extant regulations but has now been withdrawn. I understand that this has been done in order for the financial statements to provide a true and fair view in accordance with UK Generally Accepted Accounting Practice.
I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:
- 1 accounting records were not kept in respect of the Charity as required by section 130 of the Charities Act 2011.
- 2 the financial statements do not accord with those records; or
- 3 the financial statements do not comply with the applicable requirements concerning the form and content of financial statements set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the financial statements give a true and fair view, which is not a matter considered as part of an independent examination.
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the financial statements to be reached.
## **Darren Harding ACA FCCA DChA**
Richard Place Dobson Services Limited Ground Floor 1-7 Station Road Crawley West Sussex RH10 1HT Date: ............................30 April 2026
page 5
**INTERNATIONAL INSTITUTE FOR RESTORATIVE REPRODUCTIVE MEDICINE**
## **STATEMENT OF FINANCIAL ACTIVITIES INCLUDING INCOME AND EXPENDITURE ACCOUNT**
## _**FOR THE YEAR ENDED 30 JUNE 2025**_
|**Unrestricted**
**Restricted**
**funds**
**funds**
**2025**
**2025**
**Notes**
**£**
**£**
**Income and endowments from:**
Donations and legacies
**3**
6,638
3,754
Charitable activities
**4**
56,103
-
Other income
**5**
1,165
-
**Total income**
63,906
3,754
**Expenditure on:**
Charitable activities
**6**
62,373
2,983
**Total expenditure**
62,373
2,983
**Net income and movement in**
**funds**
1,533
771
**Reconciliation of funds:**
Fund balances at 1 July 2024
33,303
5,900
**Fund balances at 30 June 2025**
34,836
6,671|**Total**
**Unrestricted**
**Restricted**
**funds**
**funds**
**2025**
**2024**
**2024**
**£**
**£**
**£**
10,392
-
8,524
56,103
51,507
-
1,165
384
-
67,660
51,891
8,524
65,356
28,270
2,624
65,356
28,270
2,624
2,304
23,621
5,900
39,203
9,682
-
41,507
33,303
5,900|**Total**
**2024**
**£**
8,524
51,507
384|
|---|---|---|
|||60,415
30,894|
|||30,894|
|||29,521
9,682|
|||39,203|
The statement of financial activities includes all gains and losses recognised in the year. All income and expenditure derive from continuing activities.
page 6
## **INTERNATIONAL INSTITUTE FOR RESTORATIVE REPRODUCTIVE MEDICINE**
## **BALANCE SHEET**
## _**AS AT 30 JUNE 2025**_
|**2025**
**Notes**
**£**
**Current assets**
Cash at bank and in hand
58,734
**Creditors: amounts falling due within one**
**year**
**10**
(17,227)
**Net current assets**
**The funds of the Charity**
Restricted income funds
**12**
Unrestricted funds
**13**|**£**
41,507
6,671
34,836
41,507|**2024**
**£**
43,211
(4,008)|**£**
39,203|
|---|---|---|---|
||||5,900
33,303|
||||39,203|
The financial statements were approved by the trustees on April 30 2026
.............................. Dr P Boyle **Trustee**
page 7
**INTERNATIONAL INSTITUTE FOR RESTORATIVE REPRODUCTIVE MEDICINE**
## **NOTES TO THE FINANCIAL STATEMENTS**
## _**FOR THE YEAR ENDED 30 JUNE 2025**_
## **1 Accounting policies**
## **Charity information**
International Institute for Restorative Reproductive Medicine is a Charitable Incorporated Organisation.
## **1.1 Basis of preparation**
The financial statements have been prepared in accordance with the Charity's governing document, the Charities Act 2011, FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Charities SORP "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)". The Charity is a Public Benefit Entity as defined by FRS 102.
The Charity has taken advantage of the provisions in the SORP for charities not to prepare a statement of cash flows.
The financial statements have departed from the Charities (Accounts and Reports) Regulations 2008 only to the extent required to provide a true and fair view. This departure has involved following the Statement of Recommended Practice for charities applying FRS 102 rather than the version of the Statement of Recommended Practice which is referred to in the Regulations but which has since been withdrawn.
The financial statements are prepared in sterling, which is the functional currency of the Charity. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.
## **1.2 Going concern**
At the time of approving the financial statements, the trustees have a reasonable expectation that the Charity has adequate resources to continue in operational existence for the foreseeable future. Thus the trustees continue to adopt the going concern basis of accounting in preparing the financial statements.
## **1.3 Charitable funds**
Unrestricted funds are available for use at the discretion of the trustees in furtherance of their charitable objectives.
## **1.4 Income**
Income is recognised when the Charity is legally entitled to it after any performance conditions have been met, the amounts can be measured reliably, and it is probable that income will be received.
Membership subscriptions are recognised when the Charity is legally entitled to the income.
## **1.5 Expenditure**
Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement, and the amount of the obligation can be measured reliably.
Expenditure is classified by activity. The costs of each activity are made up of the total of direct costs and shared costs, including support costs involved in undertaking each activity. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources. Central staff costs are allocated on the basis of time spent, and depreciation charges are allocated on the portion of the asset’s use.
page 8
**INTERNATIONAL INSTITUTE FOR RESTORATIVE REPRODUCTIVE MEDICINE**
## **NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)**
## _**FOR THE YEAR ENDED 30 JUNE 2025**_
## **1 Accounting policies**
## **(Continued)**
## **1.6 Cash and cash equivalents**
Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less.
## _**Basic financial assets**_
Basic financial assets, such as cash and bank balances, are measured at transaction price including transaction costs.
## _**Basic financial liabilities**_
Basic financial liabilities, including creditors are recognised at transaction price. Financial liabilities classified as payable within one year are not amortised.
## **2 Critical accounting estimates and judgements**
In the application of the Charity’s accounting policies, the trustees are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
## **3 Income from donations and legacies**
|**Unrestricted**
**Restricted**
**funds**
**funds**
**2025**
**2025**
**£**
**£**
Donations and gifts
6,638
-
Grants
-
3,754
6,638
3,754|**Total**
**Unrestricted**
**Restricted**
**funds**
**funds**
**2025**
**2024**
**2024**
**£**
**£**
**£**
6,638
-
-
3,754
-
8,524
10,392
-
8,524|**Total**
**2024**
**£**
-
8,524|
|---|---|---|
|||8,524|
## **4 Income from charitable activities**
||**Unrestricted**|**Unrestricted**|
|---|---|---|
||**funds**|**funds**|
||**2025**|**2024**|
||**£**|**£**|
|**Restorative Reproductive Medicine**|||
|Membership income|23,306|19,633|
|Services provided under contract|32,797|31,874|
||56,103|51,507|
page 9
**INTERNATIONAL INSTITUTE FOR RESTORATIVE REPRODUCTIVE MEDICINE**
## **NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)**
## _**FOR THE YEAR ENDED 30 JUNE 2025**_
## **5 Other income**
||**Unrestricted**|**Unrestricted**|
|---|---|---|
||**funds**|**funds**|
||**2025**|**2024**|
||**£**|**£**|
|Other income|1,165|384|
|**Expenditure on charitable activities**|||
||**Restorative**|**Restorative**|
||**Reproductive**|**Reproductive**|
||**Medicine**|**Medicine**|
||**2025**|**2024**|
||**£**|**£**|
|**Direct costs**|||
|Event costs|37,457|13,332|
|Contractor fees|13,632|10,322|
|Office fees|859|318|
|Marketing|435|702|
|Event insurance|1,040|-|
||53,423|24,674|
|**Share of support and governance costs (see note 7)**|||
|Support|8,861|3,283|
|Governance|3,072|2,937|
||65,356|30,894|
|**Analysis by fund**|||
|Unrestricted funds|62,373|28,270|
|Restricted funds|2,983|2,624|
||65,356|30,894|
**6 Expenditure on charitable activities**
page 10
## **INTERNATIONAL INSTITUTE FOR RESTORATIVE REPRODUCTIVE MEDICINE**
## **NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)** _**FOR THE YEAR ENDED 30 JUNE 2025**_
## **7 Support costs allocated to activities**
|Bank fees
IT Costs
Exchange differences
Governance costs
**Analysed between:**
Restorative Reproductive Medicine
**Governance costs comprise:**
Accountancy
Legal and professional|**2025**
**£**
6,810
2,093
(43)
3,073
11,933
11,933
**2025**
**£**
2,094
979
3,073|**2024**
**£**
2,159
1,024
100
2,937|
|---|---|---|
|||6,220|
|||6,220|
|||**2024**
**£**
2,040
897|
|||2,937|
## **8 Trustees**
None of the trustees (or any persons connected with them) received any remuneration or benefits from the Charity during the year.
The serving board do not pay membership fees.
## **9 Taxation**
The charity is exempt from taxation on its activities because all its income is applied for charitable purposes.
## **10 Creditors: amounts falling due within one year**
|**Notes**
Deferred income
**11**
Other creditors
Accruals|**2025**
**£**
3,299
11,846
2,082
17,227|**2024**
**£**
-
-
4,008|
|---|---|---|
|||4,008|
page 11
**INTERNATIONAL INSTITUTE FOR RESTORATIVE REPRODUCTIVE MEDICINE**
## **NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)**
## _**FOR THE YEAR ENDED 30 JUNE 2025**_
|**11**
**Deferred income**
Other deferred income
Deferred income is included in the financial statements as follows:
Deferred income is included within:
Current liabilities
Movements in the year:
Deferred income at 1 July 2024
Resources deferred in the year
Deferred income at 30 June 2025|**2025**
**£**
3,299
**2025**
**£**
3,299
-
3,299
3,299|**2024**
**£**
-|
|---|---|---|
|||**2024**
**£**
-|
|||-
-|
|||-|
## **12 Restricted funds**
The restricted funds of the charity comprise the unexpended balances of donations and grants held on trust subject to specific conditions by donors as to how they may be used.
||**At 1 July 2024**|**Incoming**|**Resources**|
**At 30 June 2025**|
**At 30 June 2025**|
|---|---|---|---|---|---|
|||**resources**|**expended**|||
||**£**|**£**|**£**||**£**|
|NeoFertility Grant|5,900|-|(2,983)||2,917|
|Women's Reproductive Health Foundation Grant|-|3,754|-||3,754|
||5,900|3,754|(2,983)||6,671|
|**Previous year:**|**At 1 July 2023**|**Incoming**|**Resources**|
**At 30 June 2024**||
|||**resources**|**expended**|||
||**£**|**£**|**£**||**£**|
|NeoFertility Grant|-|8,524|(2,624)||5,900|
The NeoFertility grant has been donated with the purpose of funding clinical research, with a goal of further publication and data synthesis in the Restorative Reproductive Medicine field (RRM).
The Women's Reproductive Health Foundation Grant is a grant donated with the goal of starting the RRM journal and publishing clinical guidelines.
page 12
**INTERNATIONAL INSTITUTE FOR RESTORATIVE REPRODUCTIVE MEDICINE**
## **NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)** _**FOR THE YEAR ENDED 30 JUNE 2025**_
## **13 Unrestricted funds**
The unrestricted funds of the charity comprise the unexpended balances of donations and grants which are not subject to specific conditions by donors and grantors as to how they may be used. These include designated funds which have been set aside out of unrestricted funds by the trustees for specific purposes.
||**At 1 July 2024**|**Incoming**|**Resources**|
**At 30 June 2025**|
**At 30 June 2025**|
|---|---|---|---|---|---|
|||**resources**|**expended**|||
||**£**|**£**|**£**||**£**|
|General funds|33,303|63,906|(62,373)||34,836|
|**Previous year:**|**At 1 July 2023**|**Incoming**|**Resources**|
**At 30 June 2024**||
|||**resources**|**expended**|||
||**£**|**£**|**£**||**£**|
|General funds|9,682|51,891|(28,270)||33,303|
|**Analysis of net assets between funds**||||||
|||**Unrestricted**|**Restricted**||**Total**|
|||**funds**|**funds**|||
|||**2025**|**2025**||**2025**|
|||**£**|**£**||**£**|
|**At 30 June 2025:**||||||
|Current assets/(liabilities)||34,836|6,671||41,507|
|||34,836|6,671||41,507|
|||**Unrestricted**|**Restricted**||**Total**|
|||**funds**|**funds**|||
|||**2024**|**2024**||**2024**|
|||**£**|**£**||**£**|
|**At 30 June 2024:**||||||
|Current assets/(liabilities)||33,303|5,900||39,203|
|||33,303|5,900||39,203|
## **14 Analysis of net assets between funds**
page 13
## **INTERNATIONAL INSTITUTE FOR RESTORATIVE REPRODUCTIVE MEDICINE**
## **NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)**
## _**FOR THE YEAR ENDED 30 JUNE 2025**_
## **15 Related party transactions**
During the financial year the charity received a total of £1,590 (2024: £1,503) in regards of research sponsorship, congress registration and clinician recognition fees from Trustees.
In the previous financial year the charity did not pay any stipends to trustee's, however in 2025 there were expenses of £2,945.
IIRRM trustees are offered a speaker stipend when preparing and presenting as part of the scientific program of IIRRM's International Congress. All trustees may also elect to receive complimentary Congress registration as per IIRRM's related transaction policy. Membership dues are waived for Trustees during active years of service.
page 14